The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.00
Bid: 17.00
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 2.00 (11.765%)
Open: 18.00
High: 18.00
Low: 18.00
Prev. Close: 18.00
THRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thruvision trialed in London Underground station

16 Sep 2019 15:36

RNS Number : 4967M
Thruvision Group PLC
16 September 2019
 

Thruvision People Screening Technology to be Trialed in London Underground Station to Detect Knives in Public Places

Thruvision to Aid British Transport Police as Part of a Government Crack Down on Knife Crime

London, September 16, 2019 - Thruvision, the leading provider of next-generation people-screening solutions, today announces that its units will be deployed at Stratford Underground Station in East London for a trial aimed at safely detecting concealed knives.

The five-day trial is part of a British Government effort to eliminate knife crime. Thruvision's passive terahertz technology is already vetted and approved by the US Transportation Security Administration (TSA) and is in operational service with Los Angeles Metro. In the UK, leading British retailers, including Next and JD Sports, use Thruvision for security checking staff exiting company warehouses.

Thruvision's specialised technology will enable British Transport Police officers to identify concealed knives safely, without interfering with travel flow, eliminating the need for physical searches or pat-downs. Thruvision technology works by showing the size, shape and location of any any concealed items that block a person's body heat. This will allow officers to use experience and training to invite a person to reveal any suspicious looking items.

Thruvision is completely safe, respectful and non-instrusive. It does not show any intimate body parts and it is impossible to tell an individual's identity, gender, age or ethnicity from the imagery it produces.

"We are proud to be working with British Transport Police on this critical initiative, and we are confident our safe and non-instrusive technology can assist the police in tackling knife crime in the UK." said Colin Evans, CEO of Thruvision. "Our technology uniquely overcomes a key security challenge inherent to rail and underground networks - effectively detecting concealed weapons while maintaining traveler flow through often congested stations."

The London trial has been funded by the Home Office. Further details can be found by visiting thruvision.com or https://www.gov.uk/government/news/new-technology-to-detect-knives-in-public-places

Contacts

FTI Consulting LLP +44 (0)20 3727 1000

Matt Dixon / Shamma Kelly

 

 

About Thruvision

Thruvision is the leading provider of next-generation people-screening technology. Using patented passive terahertz technology, Thruvision is uniquely capable of detecting metallic and non-metallic threats including weapons, explosives and contraband items that are hidden under clothing at distances up to 10m. Addressing the growing need for fast, safe and effective security, Thruvision has been vetted and approved by the U.S. Transportation Security Administration. More than 250 units have been deployed worldwide in 19 countries over the last five years for applications including mass transit and aviation security, facilities and public area protection, customs, and border control and supply chain loss prevention. Thruvision has offices in Washington, D.C. and near Oxford, England. For more information, please visit www.thruvision.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAGGUWWBUPBGCQ
Date   Source Headline
18th Mar 20247:00 amRNSWalkTHRU completes operational test and evaluation
1st Feb 20247:00 amRNSNext generation product range & software launched
26th Jan 20247:00 amRNSSales Progress Update
22nd Jan 20242:48 pmRNSHolding(s) in Company
10th Jan 202410:39 amRNSAward of Share Options to Executive Director
28th Nov 202311:50 amRNSBlocklisting update
28th Nov 202311:48 amRNSBlocklisting update
20th Nov 20237:00 amRNSInterim Results
13th Nov 20238:51 amRNSUK retail theft to cost £7.9bn in 2023
6th Nov 20234:27 pmRNSNotice of Interim Results
27th Oct 202311:32 amRNSHolding(s) in Company
26th Oct 20232:34 pmRNSHolding(s) in Company
26th Oct 20232:23 pmRNSHolding(s) in Company
25th Oct 202312:04 pmRNSHolding(s) in Company
24th Oct 20237:00 amRNSResult of placing
23rd Oct 20234:35 pmRNSLaunch of placing
2nd Oct 20237:00 amRNSHalf year trading update
21st Sep 202311:12 amRNSResult of Annual General Meeting
22nd Aug 202311:56 amRNSAward of Share Options to Executive Directors
21st Jul 20237:00 amRNSResults for the year ended 31 March 2023
13th Jul 20235:09 pmRNSNotice of Results
7th Jun 20237:00 amRNSBlocklisting update
7th Jun 20237:00 amRNSBlocklisting update
21st Apr 20237:00 amRNSYear end trading update
3rd Feb 20237:00 amRNSSharesave option grant to Executive Director
12th Jan 202310:24 amRNSChange of Auditor
21st Dec 20227:00 amRNSDirector Share Dealing
19th Dec 20227:00 amRNSInterim Results
15th Dec 20227:00 amRNSCORRECTION - Blocklisting Update
13th Dec 20227:00 amRNSBlocklisting Update
13th Dec 20227:00 amRNSBlocklisting Update
30th Nov 20227:00 amRNSNotice of Results
9th Nov 20227:00 amRNSAward of Share Options to Executive Directors
8th Nov 20222:50 pmRNSHolding(s) in Company
26th Oct 202211:50 amRNSResult of AGM
12th Oct 20227:00 amRNSH1 Trading Update
3rd Oct 20227:00 amRNSCBP Framework Agreement and Contract Award
30th Sep 20227:00 amRNSResults for the Year ended 31 March 2022
22nd Sep 20223:00 pmRNSContract Award, Trading Update, Notice of Results
16th Jun 20227:00 amRNSAppointment of Chief Financial Officer
15th Jun 20228:31 amRNSHolding(s) in Company
8th Jun 20223:32 pmRNSBlocklisting update
8th Jun 20223:30 pmRNSBlocklisting update
6th May 202212:12 pmRNSDirector Share Dealing-correction & further trade
20th Apr 20227:00 amRNSDirector Share Dealing
4th Apr 20227:00 amRNSYear End Trading Update and Board Changes
1st Apr 20227:01 amRNSBlocklisting update
1st Apr 20227:00 amRNSBlocklisting update
9th Mar 202212:40 pmRNSDirector Share Dealing
21st Feb 20222:07 pmRNSExercise of Sharesave Share Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.